ANDA 214723, held by Chartwell Rx. Halcinonide.
As of Nov 13, 2026, ANDA 214723 (Halcinonide), held by Chartwell Rx, was first approved by FDA on Sep 8, 2021, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 8, 2021 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Halcinonide0.1% ยท cream;topical | Halcinonide | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed weekly; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
